SABA, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 3.803
EU - Europa 1.807
AS - Asia 1.775
SA - Sud America 426
AF - Africa 107
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.923
Nazione #
US - Stati Uniti d'America 3.726
SG - Singapore 793
UA - Ucraina 396
BR - Brasile 342
CN - Cina 308
SE - Svezia 238
RU - Federazione Russa 203
DE - Germania 198
TR - Turchia 198
IE - Irlanda 197
DK - Danimarca 151
HK - Hong Kong 145
VN - Vietnam 145
IT - Italia 133
FI - Finlandia 106
KR - Corea 80
FR - Francia 71
CI - Costa d'Avorio 61
GB - Regno Unito 51
MX - Messico 38
AR - Argentina 34
CA - Canada 31
BD - Bangladesh 21
PL - Polonia 18
ZA - Sudafrica 17
EC - Ecuador 15
ID - Indonesia 14
MA - Marocco 14
IN - India 13
JP - Giappone 13
IQ - Iraq 10
CO - Colombia 9
CL - Cile 8
PY - Paraguay 7
RO - Romania 7
AT - Austria 6
BE - Belgio 6
PK - Pakistan 6
ES - Italia 5
NL - Olanda 5
OM - Oman 5
BG - Bulgaria 4
LT - Lituania 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
IR - Iran 3
PE - Perù 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EU - Europa 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
SA - Arabia Saudita 2
TN - Tunisia 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 7.923
Città #
Singapore 477
Ashburn 403
Jacksonville 396
Chandler 350
Dallas 264
Fairfield 251
Dublin 197
Boardman 183
Wilmington 143
Hong Kong 142
New York 125
Woodbridge 120
Seattle 111
Houston 105
San Jose 99
Beijing 83
Lawrence 79
Princeton 79
San Mateo 79
Moscow 74
Ann Arbor 69
Cambridge 69
Abidjan 61
Ho Chi Minh City 59
Hefei 57
Los Angeles 56
Turin 44
São Paulo 37
Buffalo 35
Munich 29
Hanoi 28
The Dalles 22
Des Moines 20
San Diego 20
Turku 19
Warsaw 17
Denver 16
Mexico City 16
London 14
Montreal 14
Tokyo 13
Chicago 12
Atlanta 11
Johannesburg 11
Shanghai 11
Brasília 10
Izmir 10
Santa Clara 10
Wuhan 10
Orem 9
Phoenix 9
Rio de Janeiro 9
Stockholm 9
Da Nang 8
Guangzhou 8
Helsinki 8
Poplar 8
Biên Hòa 7
Columbus 7
Falls Church 7
Guayaquil 7
Haiphong 7
Belo Horizonte 6
Brooklyn 6
Buenos Aires 6
Jakarta 6
Norwalk 6
Nuremberg 6
Querétaro 6
Aracaju 5
Brussels 5
Can Tho 5
Chennai 5
Curitiba 5
Dhaka 5
Kazan' 5
Kilburn 5
Maceió 5
Quận Bình Thạnh 5
Ankara 4
Baghdad 4
Boston 4
Campinas 4
Canoas 4
Duque de Caxias 4
Manchester 4
Maricá 4
Montevideo 4
Muscat 4
Ottawa 4
Palermo 4
Paris 4
Venice 4
Wuxi 4
Augusta 3
Campobasso 3
Cape Town 3
Caxias do Sul 3
Charlotte 3
Contagem 3
Totale 4.833
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 234
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 211
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 183
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 179
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 144
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 138
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 136
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 133
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 127
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 125
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 125
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 124
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 120
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 113
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 113
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 113
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 112
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 110
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 109
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 108
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 107
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 106
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 106
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 105
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 103
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 103
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 102
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 101
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 101
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 101
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 100
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 100
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 99
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 99
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 98
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 98
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 98
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 97
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 95
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 92
LL-37 protects rats against lethal gram-negative sepsis. 90
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 90
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 89
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 89
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 88
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 87
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 86
Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage in Euro-Collins and University of Wisconsin solutions 85
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 85
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 85
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 84
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 84
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 84
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 83
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients 82
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 81
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 80
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 79
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 79
Potential therapeutic role of cationic peptides in three experimental models of septic shock 77
Mupirocin as prophylactic agent against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate Staphylococcus epidermidis vascular graft infection. 77
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 77
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 76
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 75
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 75
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 74
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 72
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides 71
Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model Infected with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides 71
Single-dose intraperitoneal magainins improve survival in a gram-negative pathogens septic shock rat model. 70
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 70
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 70
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 69
Valore prognostico dell'indice Apache II nell'impiego routinario preoperatorio in chirurgia generale maggiore 68
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine models of staphylococcal sepsis 66
Temporin A as prophylactic agent against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. 65
Interaction of antimicrobial peptide temporin L with lipopolisaccharide in vitro and in experimental rat models of Gram-negative septic shock. 64
RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections 64
RNA III Inhibiting Peptide (RIP) inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus 64
Temporin A alone and in combination with imipenem reduces lethality in mouse models of staphylococcal sepsis 63
A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging 58
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins 43
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people 28
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc 27
Totale 8.012
Categoria #
all - tutte 36.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.967


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021536 0 0 0 0 0 0 104 74 114 91 104 49
2021/2022583 51 122 0 27 3 54 15 30 35 92 24 130
2022/20231.040 106 114 91 81 91 106 0 50 286 7 84 24
2023/2024518 109 12 22 88 89 122 5 5 3 4 13 46
2024/20251.462 171 100 93 82 63 95 163 69 260 55 140 171
2025/20262.134 210 371 329 425 371 268 160 0 0 0 0 0
Totale 8.012